Gilgamesh Pharma Inc. research brief

CIK 2107396 Copy CIK

Generated Nov. 7, 2026, 10:45 p.m. from up to 100 stored Form D disclosures. A CIK identifies a filer, not a single offering.

Current stored business address: NEW YORK NY. Reported legal jurisdiction: DELAWARE. These do not establish investor residence or where funds were deployed.

• March 31, 2026 · D · 0002107396-26-000004 · Source evidence

  Reported offering amount: 15000000 USD. Reported amount sold: 2250000 USD.

• March 24, 2026 · D · 0002107396-26-000003 · Source evidence

  Reported offering amount: 60000000 USD. Reported amount sold: 60000000 USD.

• Feb. 4, 2026 · D · 0002107396-26-000002 · Source evidence

  Reported offering amount: 6090946 USD. Reported amount sold: 6090946 USD.

• Feb. 4, 2026 · D · 0002107396-26-000001 · Source evidence

  Reported offering amount: 4366118 USD. Reported amount sold: 0 USD.

Reviewed offering links

• No independently reviewed offering relationship is recorded. Adjacent filings are not assumed to belong to one offering.

Citation: Form D Explorer, “Gilgamesh Pharma Inc. research brief,” CIK 2107396, retrieved Nov. 7, 2026, 10:45 p.m.. Cite the specific accessions used. No amounts have been summed.